Pharmacogenomics

Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key
pp. 1-4(4)
Author: Payne, Katherine

Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics
pp. 5-9(5)
Author: Hardiman, Gary

Genetic cause identified for statin-induced muscle pain
pp. 11-13(3)

New applications of microarray data analysis: integrating genetics with ``Omics''
pp. 15-17(3)
Author: Polychronakos, Constantin

Global analysis of genetic variation in SLCO1B1
pp. 19-33(15)
Authors: Pasanen, Marja K; Neuvonen, Pertti J; Niemi, Mikko

Pathway analysis tools and toxicogenomics reference databases for risk assessment
pp. 35-54(20)
Authors: Ganter, Brigitte; Zidek, Nadine; Hewitt, Philip R; Müüller, Dieter; Vladimirova, Antoaneta

EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach
pp. 55-69(15)
Authors: Loupakis, Fotios; Vasile, Enrico; Santini, Daniele; Masi, Gianluca; Falcone, Alfredo; Graziano, Francesco

Pharmacogenetics of the constitutive androstane receptor
pp. 71-83(13)
Author: Lamba, Jatinder K

Pharmacogenetics of aspirin-intolerant asthma
pp. 85-91(7)
Authors: Kim, Seung-Hyun; Hur, Gyu-Young; Choi, Jeong-Hee; Park, Hae-Sim

Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer
pp. 93-104(12)
Authors: Katoh, Takahiko; Yamano, Yuko; Tsuji, Mayumi; Watanabe, Masatoshi

ABC multidrug transporters: structure, function and role in chemoresistance
pp. 105-127(23)
Author: Sharom, Frances J